US FDA Loss In Device Case Might Have Implications For Agency’s Work On Off-Label Rx Promotion
Executive Summary
While the statutes at issue in the case, which revolved around banning just one use of a medical device, do not govern drugs, experts on FDA law said the decision addressing a product’s intended use and regulation of the practice of medicine could have some impact on the agency’s Rx oversight powers.